PharmaChem Technologies is a fine chemical contract manufacturing organization (CMO) that has been founded in 1967. The company's slogan, "Empowering pharmaceutical innovation with high-quality, cost-effective API solutions," encapsulates their dedication to providing top-notch Active Pharmaceutical Ingredients (API) for pharmaceutical products at an optimal cost. PharmaChem specializes in transferring process technologies from their customers to produce high-quality bulk API, effectively meeting customer demand while ensuring cost-effectiveness.
One of the most notable partnerships for PharmaChem is with Gilead Sciences Inc., a research-oriented biopharmaceutical company known for its focus on discovering, developing, and commercializing innovative medicines to address areas of unmet medical needs. This collaboration has significantly bolstered PharmaChem's position in the industry, providing valuable opportunities for growth and innovation.
With a focus on Biotechnology, Manufacturing, and Pharmaceutical industries, PharmaChem Technologies has positioned itself as a key player in supporting pharmaceutical innovation. While detailed information about their headquarters, last investment, and investors is currently unavailable, PharmaChem's long-standing presence in the industry and strategic partnership with Gilead Sciences Inc. demonstrate their potential for further growth and success in the future.
There is no investment information
No recent news or press coverage available for PharmaChem Technologies.